Christopher Astle
Equibles does not estimate personal net worth.
About Christopher Astle
Earlier roles on record: CFO at Zymeworks Inc. (ZYME) until March 31, 2024. Zymeworks Inc. reported in an 8-K filed April 4, 2024 that Christopher Astle was terminated as Senior Vice President and Chief Financial Officer, including as the Company's principal financial officer and principal accounti, effective March 31, 2024. Zymeworks Inc. reported in an 8-K filed April 1, 2024 that Christopher Astle was terminated as Senior Vice President and Chief Financial Officer, including as the Company's principal financial officer and principal accounti, effective March 31, 2024. The proxy statement of Zymeworks Inc. reports total compensation of $1,191,820 for Christopher Astle in fiscal 2023, including a base salary of $410,093. Disclosed compensation is on record for 2 fiscal years.
“effective March 31, 2024 (the "Separation Date"), Zymeworks Inc. (the "Company") removed Dr. Christopher Astle from the positions of Senior Vice President and Chief Financial Officer, including as the Company's principal financial officer and principal accounting officer.”
“On March 31, 2024, Zymeworks Inc. (the "Company") removed Dr. Christopher Astle from the positions of Senior Vice President and Chief Financial Officer, including as the Company's principal financial officer and principal accounting officer, effective immediately.”
Affiliation history
-
Start not stated–2024-03-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Zymeworks Inc. (ZYME) | Former SVP & CFO | $410,093 | $1,191,820 |
| 2022 | Zymeworks Inc. (ZYME) | Former SVP & CFO | $358,749 | $1,315,005 |